Medistim ASA (MEDI.OL)
NOK 161.0
(1.58%)
NOK 161.0
(1.58%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -144.61 Million NOK | -13.82% |
| 2022 | -127.05 Million NOK | -26.21% |
| 2021 | -100.67 Million NOK | -277.78% |
| 2020 | -26.64 Million NOK | -2.44% |
| 2019 | -26.01 Million NOK | 21.17% |
| 2018 | -33 Million NOK | 6.27% |
| 2017 | -35.2 Million NOK | -56.15% |
| 2016 | -22.54 Million NOK | 35.75% |
| 2015 | -35.09 Million NOK | -21.64% |
| 2014 | -28.85 Million NOK | -203.66% |
| 2013 | -9.5 Million NOK | 61.97% |
| 2012 | -24.98 Million NOK | 14.55% |
| 2011 | -29.23 Million NOK | 8.43% |
| 2010 | -31.92 Million NOK | -43.21% |
| 2009 | -22.29 Million NOK | -46.61% |
| 2008 | -15.2 Million NOK | -6843.38% |
| 2007 | -219 Thousand NOK | 98.67% |
| 2006 | -16.41 Million NOK | 20.98% |
| 2005 | -20.77 Million NOK | 22.92% |
| 2004 | -26.95 Million NOK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -152.9 Million NOK | -5.73% |
| 2024 Q3 | -117.32 Million NOK | -35.67% |
| 2024 Q2 | -88.33 Million NOK | 42.23% |
| 2023 Q3 | -117.4 Million NOK | -48.35% |
| 2023 Q1 | -139.87 Million NOK | -10.09% |
| 2023 Q2 | -79.13 Million NOK | 43.42% |
| 2023 FY | -144.61 Million NOK | -13.82% |
| 2023 Q4 | -144.61 Million NOK | -23.18% |
| 2022 Q2 | -90.17 Million NOK | -75.21% |
| 2022 FY | -127.05 Million NOK | -26.21% |
| 2022 Q3 | -110.7 Million NOK | -22.77% |
| 2022 Q4 | -127.05 Million NOK | -14.77% |
| 2022 Q1 | -51.46 Million NOK | 48.88% |
| 2021 Q3 | -8.88 Million NOK | -149.36% |
| 2021 Q2 | 18 Million NOK | 679.62% |
| 2021 Q4 | -100.67 Million NOK | -1032.83% |
| 2021 Q1 | -3.1 Million NOK | 88.34% |
| 2021 FY | -100.67 Million NOK | -277.78% |
| 2020 Q1 | -60.49 Million NOK | -132.53% |
| 2020 Q2 | -79.77 Million NOK | -31.87% |
| 2020 Q3 | -84.24 Million NOK | -5.61% |
| 2020 Q4 | -26.64 Million NOK | 68.37% |
| 2020 FY | -26.64 Million NOK | -2.44% |
| 2019 Q2 | 27.59 Million NOK | 159.11% |
| 2019 Q3 | 10.08 Million NOK | -63.47% |
| 2019 Q4 | -26.01 Million NOK | -358.02% |
| 2019 FY | -26.01 Million NOK | 21.17% |
| 2019 Q1 | -46.69 Million NOK | -41.49% |
| 2018 Q1 | -47.26 Million NOK | -34.25% |
| 2018 Q4 | -33 Million NOK | -20.4% |
| 2018 Q2 | 27.62 Million NOK | 158.45% |
| 2018 Q3 | -27.4 Million NOK | -199.21% |
| 2018 FY | -33 Million NOK | 6.27% |
| 2017 FY | -35.2 Million NOK | -56.15% |
| 2017 Q4 | -35.2 Million NOK | -113.79% |
| 2017 Q3 | -16.46 Million NOK | -109.52% |
| 2017 Q2 | -7.86 Million NOK | 81.23% |
| 2017 Q1 | -41.87 Million NOK | -85.71% |
| 2016 Q3 | -18.07 Million NOK | -24.8% |
| 2016 FY | -22.54 Million NOK | 35.75% |
| 2016 Q2 | -14.47 Million NOK | 61.66% |
| 2016 Q4 | -22.54 Million NOK | -24.78% |
| 2016 Q1 | -37.76 Million NOK | -7.6% |
| 2015 FY | -35.09 Million NOK | -21.64% |
| 2015 Q1 | -42 Million NOK | -45.61% |
| 2015 Q2 | -19.21 Million NOK | 54.26% |
| 2015 Q3 | -29.97 Million NOK | -55.97% |
| 2015 Q4 | -35.09 Million NOK | -17.1% |
| 2014 Q3 | -20.85 Million NOK | -64.97% |
| 2014 Q1 | -16.47 Million NOK | -73.39% |
| 2014 FY | -28.85 Million NOK | -203.66% |
| 2014 Q4 | -28.85 Million NOK | -38.36% |
| 2014 Q2 | -12.64 Million NOK | 23.27% |
| 2013 Q4 | -9.5 Million NOK | -21.87% |
| 2013 Q2 | -1.97 Million NOK | 92.92% |
| 2013 Q1 | -27.92 Million NOK | -11.79% |
| 2013 FY | -9.5 Million NOK | 61.97% |
| 2013 Q3 | -7.79 Million NOK | -294.33% |
| 2012 Q2 | -20.03 Million NOK | 36.97% |
| 2012 Q1 | -31.79 Million NOK | -8.75% |
| 2012 Q3 | -22.35 Million NOK | -11.58% |
| 2012 FY | -24.98 Million NOK | 14.55% |
| 2012 Q4 | -24.98 Million NOK | -11.74% |
| 2011 Q2 | -26.62 Million NOK | 26.7% |
| 2011 Q4 | -29.23 Million NOK | -11.5% |
| 2011 FY | -29.23 Million NOK | 8.43% |
| 2011 Q1 | -36.32 Million NOK | -13.76% |
| 2011 Q3 | -26.22 Million NOK | 1.51% |
| 2010 FY | -31.92 Million NOK | -43.21% |
| 2010 Q3 | -26.8 Million NOK | -31.6% |
| 2010 Q2 | -20.37 Million NOK | 38.74% |
| 2010 Q1 | -33.25 Million NOK | -49.16% |
| 2010 Q4 | -31.92 Million NOK | -19.1% |
| 2009 FY | -22.29 Million NOK | -46.61% |
| 2009 Q4 | -22.29 Million NOK | 0.0% |
| 2008 FY | -15.2 Million NOK | -6843.38% |
| 2007 FY | -219 Thousand NOK | 98.67% |
| 2006 FY | -16.41 Million NOK | 20.98% |
| 2005 FY | -20.77 Million NOK | 22.92% |
| 2004 FY | -26.95 Million NOK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Gentian Diagnostics ASA | -78.63 Million NOK | -83.901% |
| Lifecare AS | -41.89 Million NOK | -245.178% |